Yüklüyor......
CARs in the lead against Multiple Myeloma
The recent clinical success of CD19 directed chimeric antigen receptor (CAR) T-cell therapy in chronic and acute leukemia has led to increased interest in broadening this technology to other hematological malignancies and solid tumors. Now, advances are being made using CAR T cell technology to targ...
Kaydedildi:
| Yayımlandı: | Curr Hematol Malig Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410390/ https://ncbi.nlm.nih.gov/pubmed/28233151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0373-2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|